Free | 45 minutes | 0.75 hour COPE
Instructors:
David Wirta, OD
Selina Riann McGee, OD, FAAO
Increased understanding of the neurobiology of dry eye disease (DED) has led to a greater appreciation of its significant and potentially serious impact on patients’ vision and quality of life. Emerging treatments for DED go beyond mere symptom management to target its neurobiology. Join an expert panel consisting of an ophthalmologist and an optometrist to discuss the burden and causes of DED, the role of the lacrimal functional unit (LFU) in DED pathophysiology, and the rationale for targeted neuromodulation. The panel will also explore the symptoms of DED and the new pharmacologic agents that target the LFU, along with clinical evidence supporting their use. The program will also include a video vignette of a patient with DED to highlight the challenges and realities of living with DED.
Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the New England College of Optometry (NECO).